Ryght AI Launches Free AI-Powered Clinical Trial Site Search Engine
Ryght AI has launched RyghtSites.com, a free AI-powered clinical trial site search engine, announced in a press release. The platform allows pharmaceutical companies and Contract Research Organizations (CROs) to search, rank, and download lists of clinical research sites across 192 countries.
The tool uses Ryght’s proprietary AI Site Twins technology to digitally represent over 100,000 research sites, enabling users to identify the most suitable locations for clinical trials based on real-world performance data. Users can filter by disease, biomarker, or region, and download site data in CSV format.
RyghtSites.com supports all phases of clinical trials, from Phase 1 to Phase 4, and ranks sites automatically using an agentic ranking system that assesses feasibility and historical fit. The company said the platform removes the need for traditional manual research and costly data vendor contracts.
According to Ryght AI, its technology has previously reduced clinical site selection timelines from six months to under a month for large CROs. The company stated that RyghtSites.com is intended to make this capability freely available to the global research community.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
MediSights Reports Study Using AI Agents for Myeloma Market Research
TRI Launches TRIAL.OS for Clinical Trial Management
AI in Clinical Trials Market Forecast to Reach USD 7.32 Billion by 2034
Apodex Offers Free AI Drug Research Services
Truven launches MarketScan Snapshot for healthcare data checks
Daily AI Brief: the AI news that matters, in your inbox.